GB0519478D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0519478D0
GB0519478D0 GB0519478A GB0519478A GB0519478D0 GB 0519478 D0 GB0519478 D0 GB 0519478D0 GB 0519478 A GB0519478 A GB 0519478A GB 0519478 A GB0519478 A GB 0519478A GB 0519478 D0 GB0519478 D0 GB 0519478D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0519478A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0519478A priority Critical patent/GB0519478D0/en
Publication of GB0519478D0 publication Critical patent/GB0519478D0/en
Application status is Ceased legal-status Critical

Links

GB0519478A 2005-09-23 2005-09-23 Compounds Ceased GB0519478D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0519478A GB0519478D0 (en) 2005-09-23 2005-09-23 Compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0519478A GB0519478D0 (en) 2005-09-23 2005-09-23 Compounds
PCT/EP2006/009237 WO2007039145A1 (en) 2005-09-23 2006-09-21 C (2) -heteroarylmethyl-c (4) -pyrazinyl-2-yl acyl pyrrolidine compounds and their use for treating viral infections, especially hepatitis c virus

Publications (1)

Publication Number Publication Date
GB0519478D0 true GB0519478D0 (en) 2005-11-02

Family

ID=35335379

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0519478A Ceased GB0519478D0 (en) 2005-09-23 2005-09-23 Compounds

Country Status (2)

Country Link
GB (1) GB0519478D0 (en)
WO (1) WO2007039145A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
KR20110098849A (en) 2008-12-23 2011-09-01 파마셋 인코포레이티드 Nucleoside analogs
CN102695513A (en) 2008-12-23 2012-09-26 吉利德制药有限责任公司 Nucleoside phosphoramidates
EP2671888A1 (en) 2008-12-23 2013-12-11 Gilead Pharmasset LLC 3',5'-cyclic nucleoside phosphate analogues
TWI583692B (en) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 Nucleoside phosphoramidates
AR080870A1 (en) 2010-03-31 2012-05-16 Pharmasset Inc Propanoate crystal (s) -isopropyl 2 - (((s) - (((2R, 3R, 4R, 5R) -5- (2,4-dioxo-3,4-dihydro-1 (2H) -yl) -4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl) methoxy) (phenoxy) phosphoryl) amino, pharmaceutical compositions containing them and use thereof in treating viral infections, in particul
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
UY33312A (en) 2010-03-31 2011-10-31 Pharmasset Inc Phosphoramidate purinenucleoside
ES2716158T3 (en) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleotides for the treatment of hepatitis C
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370137T (en) * 2001-11-02 2007-09-15 Glaxo Group Ltd 4- (6-low) heteroaryl acyl-pyrrolidine derivatives as hcv inhibitors
AT418554T (en) * 2002-10-24 2009-01-15 Glaxo Group Ltd 1-acyl-pyrrolidin derivatives for the treatment of viral infections

Also Published As

Publication number Publication date
WO2007039145A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
DE502006001600D1 (en) Pyrazolylcarboxanilide
DE602006018441D1 (en) Arabinofuranosidasen
GB0510139D0 (en) Novel compounds B1
DE602006013270D1 (en) Prrs-impfstoffe
DE602006021475D1 (en) Carbonylierungsverfahren
SI1893196T2 (en) Diarylhydantoin compound
GB0500492D0 (en) Compound
GB0508472D0 (en) Compounds
GB0506133D0 (en) Compound
GB0513702D0 (en) Compound
GB0503962D0 (en) Compounds
GB0504994D0 (en) Novel compounds
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
GB0507602D0 (en) Compounds
GB0517191D0 (en) Compounds
GB0516462D0 (en) Novel compounds
IL190803D0 (en) Compounds
GB0502418D0 (en) Compounds
GB0522880D0 (en) Novel compounds
GB0502482D0 (en) Novel compounds
DE602006020169D1 (en) Differential-bogendraht
GB0502316D0 (en) Compounds
GB0514809D0 (en) Compounds
EP1961741A4 (en) m-CARBAZOLYLPHENYL COMPOUNDS
GB0513297D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)